Plain-English translation of NCT06128252 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding an oral supplement called taurine to a combination of immunotherapy () and chemotherapy can help people with advanced stomach or gastric junction cancer more than immunotherapy and chemotherapy alone. The study wants to see if taurine helps boost your immune system's ability to fight cancer cells. Half of the participants will receive taurine plus the immunotherapy and chemotherapy, while the other half will receive a placebo pill plus the same immunotherapy and chemotherapy.
Immunotherapy is a promising treatment for stomach cancer, but doctors want to find ways to make it even more effective. This medication helps your immune system attack cancer, and early research suggests that taurine might help strengthen that immune response.
You likely qualify if…
You likely don't qualify if…
You would receive chemotherapy and immunotherapy injections as part of standard treatment, and you would also take a daily oral supplement (either taurine or a placebo that looks identical). You would attend regular clinic visits for blood tests, imaging scans, and doctor check-ins to monitor how you're responding to treatment. After completing the chemotherapy and immunotherapy phase, you would have surgery to remove your tumor, and the research team would follow your recovery and health over time to see which group had better outcomes.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China